Time-Restricted Eating for Cancer-Related Fatigue

AK
Overseen ByAmber Kleckner, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Maryland, Baltimore
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores whether time-restricted eating can reduce cancer-related fatigue in cancer survivors. Participants will either follow a time-restricted eating plan, consuming all food within a 10-hour window, or receive general health tips without altering their eating schedule. The study seeks individuals who completed cancer treatments like chemotherapy or surgery in the last 2 years and are experiencing ongoing fatigue. Participants should own a smartphone and be willing to use it for the study. The goal is to determine if this eating pattern can ease fatigue and improve overall health. As an unphased study, this trial allows participants to contribute to innovative research that could enhance the quality of life for cancer survivors.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications. However, if you are taking insulin or have any contraindications to the nutrition intervention, you may not be eligible to participate.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research has shown that time-restricted eating is safe for people with cancer. One study found it helped reduce fatigue without causing major side effects. Another study found it was not only feasible but also easy for participants to follow. These findings suggest that time-restricted eating could help lessen cancer-related fatigue while remaining safe for participants.12345

Why are researchers excited about this trial?

Most treatments for cancer-related fatigue focus on medications, physical therapy, or cognitive behavioral therapy. However, time-restricted eating, the treatment under study, is unique because it offers a non-invasive approach by regulating the timing of food intake rather than altering diet content. Participants choose a 10-hour window for eating, which may help sync their eating patterns with natural circadian rhythms, potentially improving energy levels and reducing fatigue. Researchers are particularly excited about this approach as it encourages a healthy lifestyle without the need for medication, making it a potentially easy and natural way to combat fatigue in cancer survivors.

What evidence suggests that time-restricted eating might be an effective treatment for cancer-related fatigue?

Research has shown that time-restricted eating (TRE), a treatment under study in this trial, might help reduce tiredness in cancer survivors. Studies found that eating only during a 10-hour window each day can moderately improve fatigue. This method is safe and easy for cancer survivors to follow. It may also enhance overall well-being by helping to regulate the body's internal clock. Early results suggest that TRE could offer additional health benefits for those recovering from cancer.12346

Are You a Good Fit for This Trial?

This trial is for cancer survivors who are at least 18 years old, have completed their main treatments between 2 months and 2 years ago, can use a smartphone, speak English, and consent to study procedures. They must feel fatigued (score of 4+ on a scale of 0-10) but not be underweight or have conditions like type 1 diabetes that could complicate the diet intervention.

Inclusion Criteria

Be willing and able to adhere to study procedures, including use of a smartphone app
Own a smartphone
Be able to provide informed consent
See 3 more

Exclusion Criteria

I am currently taking insulin.
I do not have conditions like type 1 diabetes, risk for low blood sugar, specific medication needs, pregnancy, breastfeeding, or a recent eating disorder that would prevent me from following the study's diet plan.
Already eat all their food within a window that is 10 h or shorter most (6/7) days of the week
See 3 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants engage in a 12-week time-restricted eating intervention or receive general health education

12 weeks
Weekly educational tips (virtual)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Healthy lifestyle education
  • Time-restricted eating
Trial Overview The study tests if restricting eating to a 10-hour window each day for 12 weeks reduces fatigue in cancer survivors compared to those receiving general health education. Participants will be randomly assigned to either time-restricted eating or control group in equal numbers.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Group I: Time-restricted eatingExperimental Treatment2 Interventions
Group II: ControlExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Maryland, Baltimore

Lead Sponsor

Trials
729
Recruited
540,000+

National Center for Advancing Translational Sciences (NCATS)

Collaborator

Trials
394
Recruited
404,000+

Published Research Related to This Trial

Time-restricted eating (TRE) significantly reduces body weight and fat mass, with an average weight loss of 1.60 kg and fat loss of 1.48 kg in a meta-analysis of 17 studies involving 899 participants.
TRE particularly benefits overweight individuals, leading to improvements in lipid profiles, including lower triglycerides, total cholesterol, and LDL cholesterol, although it does not significantly affect waist circumference or blood pressure.
Metabolic Efficacy of Time-Restricted Eating in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Liu, L., Chen, W., Wu, D., et al.[2022]
Time-restricted eating (TRE) has shown promising therapeutic effects in rodent studies, particularly in relation to body weight and metabolic health, but results in humans are inconsistent due to varying study designs and populations.
This review highlights the need for more standardized research on TRE in humans to better understand its effects and interactions with circadian biology, as well as to identify gaps in current knowledge for future studies.
Complex physiology and clinical implications of time-restricted eating.Petersen, MC., Gallop, MR., Flores Ramos, S., et al.[2023]
In a 12-week study involving 14 adults with obesity, time-restricted feeding (8-hour eating window) led to a significant weight loss of about 2 kg, indicating potential efficacy for weight management.
Despite the weight loss, the study found no significant changes in the diversity or composition of the gut microbiome, suggesting that time-restricted feeding may not impact gut health in terms of microbial diversity.
Effect of time restricted feeding on the gut microbiome in adults with obesity: A pilot study.Gabel, K., Marcell, J., Cares, K., et al.[2022]

Citations

Clinical Impact of Time-restricted Eating on CancerPreliminary findings suggest that TRE is feasible and acceptable by people with cancer, may have oncological benefits, and improves quality of life.
Funded Grants | Division of Cancer PreventionIt is hypothesized that time-restricted eating can relieve cancer-related fatigue in blood cancer survivors via regulating circadian rhythm and improving ...
Time-restricted eating to address persistent cancer-related ...In a randomized controlled trial, we tested the effects of TRE vs. control on fatigue in cancer survivorship.
Time-restricted Eating to Address Cancer-related Fatigue ...A 10-h TRE intervention was feasible and safe among survivors, and fatigue improved with a moderate effect size after two weeks.
Time-restricted eating to address persistent cancer-related ...In a randomized controlled trial, we tested the effects of TRE vs. control on fatigue in cancer survivorship. Methods Adult cancer survivors ...
Time Restricted Eating During Chemotherapy for Breast ...Pre-clinical murine studies report intermittent fasting increases effectiveness of chemotherapy and decreases treatment related adverse events. The proposed ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security